Survival in chronic myelogenous leukemia: influence of treatment and extent of disease at diagnosis.
D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001772:Blood Cell Count; D003036:Cobalt Isotopes; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality* / Q000532:radiotherapy; D010759:Phosphorus Isotopes / Q000627:therapeutic use; D011867:Radioisotope Teletherapy; D012189:Retrospective Studies; D013154:Spleen / Q000528:radiation effects; D013997:Time Factors
D000970:Antineoplastic Agents; D003036:Cobalt Isotopes; D006454:Hemoglobins; D010759:Phosphorus Isotopes